Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt flag Egypt · Delayed Price · Currency is EGP
75.04
-0.86 (-1.13%)
At close: Jun 4, 2025
-8.26%
Market Cap 1.73B
Revenue (ttm) 1.30B
Net Income (ttm) 400.85M
Shares Out 22.75M
EPS (ttm) n/a
PE Ratio 4.31
Forward PE n/a
Dividend 4.00 (5.27%)
Ex-Dividend Date Nov 13, 2024
Volume 69,377
Average Volume 149,055
Open 75.90
Previous Close 75.90
Day's Range 75.00 - 77.00
52-Week Range 31.00 - 102.50
Beta 0.23
RSI 42.35
Earnings Date May 14, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ... [Read more]

Industry Pharmaceutical Preparations
Founded 1940
Employees 144
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MPCI
Full Company Profile

Financial Performance

In 2024, EGX:MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.

Financial Statements

News

There is no news available yet.